Dr. Anita Hill, who specializes in paroxysmal nocturnal hemoglobinuria (PNH) and in marrow failure, discusses the effects on quality of life of new therapies.
Results from a phase 3 trial showed no improvement in disease-free survival with cisplatin, and a significantly worse colostomy rate. Medscape Medical News
Estrogens behave as protective agents on the development of colorectal cancer, and hormonal-replacement therapy is associated with an increased survival rate in women with this disease. Expert Review of Endocrinology and Metabolism
Uninsured patients and those covered by Medicaid are far more likely to present with advanced-stage cancer at diagnosis than those with private coverage. Medscape Medical News
These summaries highlight important data presented at the 2008 Gastrointestinal Cancers Symposium in the areas of pancreatic and colorectal cancers. Medscape Hematology-Oncology
